Buradasınız

Timolol Göz Damlasına Bağlı Kardiyak Arrest

Cardiac Arrest Due to Timolol Ophthalmic Solution

Journal Name:

Publication Year:

Keywords (Original Language):

Abstract (2. Language): 
Timolol is a nonselective β-adrenerjic blocking agent used for the treatment of glaucoma. It can be absorbed from the conjunctiva and cause systemic side effects such as bradicardia, heart failure and bronchospasm. In this article, we reported a case who has a history of asthma, had respiratory and cardiac arrest after administration of timolol ophthalmic solution for treatment of acute glaucoma crisis. The case was admitted to the intensive care unit after cardiopulmonary resuscitation, and mechanical ventilation and medical treatment were begun. The patient who was conscious and had normal blood gas levels was extubated after the 3th day of her treatment and transferred to the Chest Medicine Department
Abstract (Original Language): 
Timolol, glokom tedavisinde kullanılan non-selektif β-adrenerjik blokerdir. Konjonktivadan absorbe olarak bradikardi, kalp yetmezliği ve bronkospazm gibi sistemik yan etkilere yol açabilir. Bu yazıda astım anamnezi olan ve akut glokom krizi nedeniyle oftalmik timolol solüsyonun uygulanmasından sonra bronkospazm ve kardiyak arrest gelişen bir olguyu sunduk. Kardiyopulmoner resüsitasyonu takiben reanimasyon ünitesine alınan olguya mekanik ventilasyon ve medikal tedavi başlandı. Şuuru açılan ve kan gazı değerleri normal olan olgu, tedavisinin 3.günü ekstübe edilerek Göğüs Hastalıkları Kliniği’ne devredildi.
79-80

REFERENCES

References: 

1. Hoffman BB. Catecholamines, sympathomimetic drugs, &
adrenergic receptor antagonists. In: Hardman JG, Limbird LE
(eds). The pharmacological basis of therapeutics. 10th edition.
USA: Mc Graw Hill Companies; 2001. 215-68.
2. Dunn TL, Gerber MJ, Shen AS et al. The effect of topical
ophtalmic instillation of timolol and betaxolol on lung
function in asthmatic subjects. Am Rev Respir Dis 1986; 133:
264-8.
3. Charan NB, Lakshminarayan S. Pulmonary effects of topical
timolol. Arch Intern Med 1980; 140: 843-4.
4. Schoene RB, Martin TR, Charan NB, French CL. Timolol
induced bronchospasm in asthmatic bronchitis. JAMA 1981;
245: 1460-1.
5. Ostergaad Laursen S, Bjerrum P. Timolol eyedrop-induced
severe bronchospasm. Acta Med Scand 1982; 211: 505-6.
6. Botet C, Grau J, Benito P, Coll J, Vivancos J. Timolol
ophthalmic solution and respiratory arrest. Ann Intern Med
1986; 105: 306-7.
7. Fraunfelder FT, Barker AF. Respiratory effects of timolol. N
Engl J Med. 1984; 311: 1441.
8. Diggory P, Cassels-Brown A, Vail A, Abbey LM, Hillman JS.
Avoiding unsuspected respiratory side-effects of topical
timolol with cardioselective or sympathomimetic agents.
Lancet 1995; 345: 1604-6.
9. Schoene RB, Abuan T, Ward RL, Beasley CH. Effets of
topical betaxolol, timolol, and placebo on pulmonary function
in asthmatic bronchitis. Am J Ophthalmol 1984; 97: 86-92.
10. Novack GD, O’Donnell MJ, Molloy DW. New glaucoma
medications in the geriatric population: efficacy and safety. J
Am Geriatr Soc. 2002; 50: 956-62.
11. Prince DS, Carliner NH. Respiratory arrest following first
dose of timolol ophthalmic solution. Chest 1983; 84: 640-1.

Thank you for copying data from http://www.arastirmax.com